Understanding Tricuspid Regurgitation Post Cardiac Transplantation; Why "Anatomical" and "Functional" Just Won't Cut It

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved..

Tricuspid regurgitation (TR) is common after cardiac transplantation and results in poorer outcomes. Transplant recipients are at high prohibitive risk for redo surgical procedures because of risks associated with a subsequent sternotomy, immunosuppression, and renal failure. Percutaneous therapies have recently become available and may be an option for transplant recipients. However, transplant recipients have complex geometry, and there is a myriad of causes of TR posttransplant. There is a need for careful patient selection for all percutaneous valve interventions, and this is particularly true in transplant recipients who suffer from right ventricular failure and rejection and may undergo repeated endomyocardial biopsies. Cognizant of the rapid developments in this space, this review article focuses on the causes of TR, treatments, and future therapies in heart transplantation recipients to the transplant cardiologist navigate this complex area.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:108

Enthalten in:

Transplantation - 108(2024), 3 vom: 01. Feb., Seite 662-668

Sprache:

Englisch

Beteiligte Personen:

Bart, Nicole K [VerfasserIn]
Macdonald, Peter S [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Review

Anmerkungen:

Date Completed 23.02.2024

Date Revised 26.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1097/TP.0000000000004740

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360777295